Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.
about
Prognosis Research Strategy (PROGRESS) 3: prognostic model researchSystematic review of risk prediction models for diabetes after bariatric surgery.A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis.The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data SetsEvaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.One statistical test is sufficient for assessing new predictive markersAge at quitting smoking as a predictor of risk of cardiovascular disease incidence independent of smoking status, time since quitting and pack-years.Everything you always wanted to know about evaluating prediction models (but were too afraid to ask).The clinical decision analysis using decision treeModeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran.Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis.Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.Risk prediction models of breast cancer: a systematic review of model performances.Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?Statistical models for respiratory disease diagnosis and prognosis.Multigene panels in prostate cancer risk assessment: a systematic review.Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.Key steps and common pitfalls in developing and validating risk models.A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressiveness.Improving multivariable prostate cancer risk assessment using the Prostate Health Index.A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.Reconsidering lactate as a sepsis risk biomarker.Zinc protoporphyrin levels have added value in the prediction of low hemoglobin deferral in whole blood donors.A minimal net reclassification improvement to assess predictions of intensive care mortality.Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model.Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
P2860
Q28709215-6A89F19D-9C29-4CAE-A466-B953B7900B1CQ30392184-EC83AF68-AEC8-47B8-84BA-E7645AC656EFQ30585625-0062CE6C-2CEE-49EA-BB77-55682623EBF2Q31011669-D7BC293B-5642-4E13-85A8-672B5E077D66Q33791377-B83DA80F-508F-4CA9-A25E-9723583F22DBQ33806366-A11AE850-3EC1-43DC-86C4-F29B0F29A30AQ33821413-D83373CF-CE5B-470C-8579-5F4A90538DC2Q34384330-A1154AA7-B269-4E4A-93C3-41511B36350AQ34608270-0FF250D7-1E9A-41BB-86DF-B652FE041B05Q35804458-39AE8AFC-4F13-4A02-9EB2-21A3DD295C36Q36287943-680F2ECF-5028-4AC9-A10A-AB57BACC5BF3Q36887649-1C6E459A-F035-471D-B9C4-11BF230AF07EQ37130232-4BE4F00D-304C-4752-9271-4F23A613C424Q37955078-A81F6B0E-A0A5-4058-B5B3-203F42E1C3FAQ38017952-FAAC9F39-C63A-4569-8E22-1086E96D90C9Q38396217-DCE5C82C-4EA4-413B-8349-5A971828199CQ38596777-34FD05A8-7D94-471D-9FB7-554589F97321Q38794258-694A5212-FA9A-403A-9C9C-238C0E895256Q38881882-68EC9229-2A59-4B11-9518-24EC63B5FDE0Q38957244-8FB9B38C-376D-41E8-8ACA-3AD96E50D54DQ40211476-0FFEEB1C-5DBB-4C34-AB40-23708BE125F4Q40270088-6C0538DD-7D30-4D72-B939-0BE7CD96BD8CQ40641438-33B6BDBC-0982-4EF1-8483-53A6622651F4Q42369456-AD4BE13E-B90C-4867-B7DF-B9505107E976Q44243091-62106AAC-BD0E-4F86-8D8E-24A9BC28A7B8Q45343601-9ED155BC-E5F0-4119-AC85-2276479CB30AQ47234627-CD9FBB39-C303-4EE3-8122-BEC0C6F124CCQ52385231-31104693-B1D5-4894-828F-6212A6858FE9Q52695031-11F1DAA4-DF92-4534-BF03-055D38A42B9F
P2860
Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Traditional statistical method ...... a decision analytic framework.
@ast
Traditional statistical method ...... a decision analytic framework.
@en
type
label
Traditional statistical method ...... a decision analytic framework.
@ast
Traditional statistical method ...... a decision analytic framework.
@en
prefLabel
Traditional statistical method ...... a decision analytic framework.
@ast
Traditional statistical method ...... a decision analytic framework.
@en
P2860
P1433
P1476
Traditional statistical method ...... a decision analytic framework.
@en
P2093
Angel M Cronin
P2860
P356
10.1053/J.SEMINONCOL.2009.12.004
P577
2010-02-01T00:00:00Z